Skip to main content
Top
Published in: Journal of General Internal Medicine 4/2007

01-04-2007 | Original Article

Factors Influencing Physicians’ Screening Behavior for Liver Cancer Among High-risk Patients

Authors: Tung T. Nguyen, MD, Ginny Gildengorin, PhD, Amy Truong, Stephen J. McPhee, MD

Published in: Journal of General Internal Medicine | Issue 4/2007

Login to get access

Abstract

BACKGROUND

Little is known about physicians’ screening patterns for liver cancer despite its rising incidence.

OBJECTIVE

Describe physician factors associated with liver cancer screening.

DESIGN

Mailed survey.

PARTICIPANTS

Physicians practicing in family practice, internal medicine, gastroenterology, or nephrology in 3 northern California counties in 2004.

MEASUREMENTS

Sociodemographic and practice measures, liver cancer knowledge, attitudes, and self-reported screening behaviors.

RESULTS

The response rate was 61.8% (N = 459). Gastroenterologists (100%) were more likely than Internists (88.4%), family practitioners (84.2%), or nephrologists (75.0%) to screen for liver cancer in high-risk patients (p = 0.016). In multivariate analysis, screeners were more likely than nonscreeners to think that screening for liver cancer reduced mortality (odds ratio [OR] 1.60, CI 1.09–2.34) and that not screening was a malpractice risk (OR 1.88, CI 1.29–2.75). Screeners were more likely than nonscreeners to order any screening test if it was a quality of care measure (OR 4.39, CI 1.79–10.81).

CONCLUSIONS

Despite debate about screening efficacy, many physicians screen for liver cancer. Their screening behavior is influenced by malpractice and quality control concerns. More research is needed to develop better screening tests for liver cancer, to evaluate their effectiveness, and to understand how physicians behave when there is insufficient evidence.
Literature
1.
go back to reference Parkin DM, Whelan SL, Ferlay J, et al., eds. Cancer Incidence in Five Continents 1993–1997. Lyon, France: IARC Scientific Publications; 2002. Parkin DM, Whelan SL, Ferlay J, et al., eds. Cancer Incidence in Five Continents 1993–1997. Lyon, France: IARC Scientific Publications; 2002.
2.
go back to reference Ries LAG, Eisner MP, Kosary CL, et al., eds. SEER Cancer Statistics Review, 1973–1998. Bethesda, MD: National Cancer Institute; 2001. Ries LAG, Eisner MP, Kosary CL, et al., eds. SEER Cancer Statistics Review, 1973–1998. Bethesda, MD: National Cancer Institute; 2001.
3.
go back to reference Sherman M. Screening for hepatocellular carcinoma. Bailliere’s Best Pract Res Clin Gastroenterol. 1999;13(4):623–35.CrossRef Sherman M. Screening for hepatocellular carcinoma. Bailliere’s Best Pract Res Clin Gastroenterol. 1999;13(4):623–35.CrossRef
4.
go back to reference Sakuma KS, Kasai M, Jitsukawa H, et al. Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: a prospective study. Hepatology. 1988;8(6):1642–6.PubMedCrossRef Sakuma KS, Kasai M, Jitsukawa H, et al. Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: a prospective study. Hepatology. 1988;8(6):1642–6.PubMedCrossRef
5.
go back to reference Morris CR, Cohen R, Perkins CI, et al. Cancer in California 1988–1996. Sacramento, CA: California Department of Health Services, Cancer Surveillance Section; 1999. Morris CR, Cohen R, Perkins CI, et al. Cancer in California 1988–1996. Sacramento, CA: California Department of Health Services, Cancer Surveillance Section; 1999.
7.
go back to reference De Masi S, Tosti ME, Mele A. Screening for hepatocellular carcinoma. Dig Liver Dis. 2005;37(4):260–8.PubMedCrossRef De Masi S, Tosti ME, Mele A. Screening for hepatocellular carcinoma. Dig Liver Dis. 2005;37(4):260–8.PubMedCrossRef
9.
go back to reference Lok AS, McMahon BJ. American Association for the Study of Liver Diseases (AASLD) Practice Guidelines: Chronic Hepatitis B. Available at: https://www.aasld.org/. Accessed October 28, 2005. Lok AS, McMahon BJ. American Association for the Study of Liver Diseases (AASLD) Practice Guidelines: Chronic Hepatitis B. Available at: https://​www.​aasld.​org/​. Accessed October 28, 2005.
10.
go back to reference Chalasani N, Said A, Ness R, et al. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey. Am J Gastroenterol. 1999;94(8):2224–9.PubMedCrossRef Chalasani N, Said A, Ness R, et al. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey. Am J Gastroenterol. 1999;94(8):2224–9.PubMedCrossRef
11.
go back to reference Lee MM, Lee F, Stewart S, et al. Cancer screening practices among primary care physicians serving Chinese Americans in San Francisco. West J Med. 1999;170(3):148–55.PubMed Lee MM, Lee F, Stewart S, et al. Cancer screening practices among primary care physicians serving Chinese Americans in San Francisco. West J Med. 1999;170(3):148–55.PubMed
12.
go back to reference Lew AA, Moskowitz JM, Ngo L, et al. Effect of provider status on preventive screening among Korean-American women in Alameda County, California. Prev Med. 2003;36(2):141–9.PubMedCrossRef Lew AA, Moskowitz JM, Ngo L, et al. Effect of provider status on preventive screening among Korean-American women in Alameda County, California. Prev Med. 2003;36(2):141–9.PubMedCrossRef
13.
go back to reference Fowler FJ Jr., Bin L, Collins MM, et al. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med. 1998;104(6):526–32.CrossRef Fowler FJ Jr., Bin L, Collins MM, et al. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med. 1998;104(6):526–32.CrossRef
14.
go back to reference Voss JD, Schectman JM. Prostate cancer screening practices and beliefs. J Gen Intern Med. 2001;16(12):831–7.PubMedCrossRef Voss JD, Schectman JM. Prostate cancer screening practices and beliefs. J Gen Intern Med. 2001;16(12):831–7.PubMedCrossRef
15.
go back to reference Pateron D, Ganne N, Trinchet JC, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol. 1994;20(1):65–71.PubMedCrossRef Pateron D, Ganne N, Trinchet JC, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol. 1994;20(1):65–71.PubMedCrossRef
16.
go back to reference Zoli M, Magalotti D, Bianchi G, et al. Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer. 1996;78(5):977–85.PubMedCrossRef Zoli M, Magalotti D, Bianchi G, et al. Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer. 1996;78(5):977–85.PubMedCrossRef
17.
go back to reference McMahon BJ, Bulkow L, Harpster A, et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology. 2000;32(4 Pt 1):842–6.PubMedCrossRef McMahon BJ, Bulkow L, Harpster A, et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology. 2000;32(4 Pt 1):842–6.PubMedCrossRef
18.
go back to reference Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130(7):417–22.PubMedCrossRef Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130(7):417–22.PubMedCrossRef
19.
go back to reference Chen JG, Parkin DM, Chen QG, et al. Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen. 2003;10(4):204–9.PubMedCrossRef Chen JG, Parkin DM, Chen QG, et al. Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen. 2003;10(4):204–9.PubMedCrossRef
20.
go back to reference Collins MM, Fowler FJ Jr., Roberts RG, et al. Medical malpractice implications of PSA testing for early detection of prostate cancer. J Law Med Ethics. 1997;25(4):234–42.PubMedCrossRef Collins MM, Fowler FJ Jr., Roberts RG, et al. Medical malpractice implications of PSA testing for early detection of prostate cancer. J Law Med Ethics. 1997;25(4):234–42.PubMedCrossRef
Metadata
Title
Factors Influencing Physicians’ Screening Behavior for Liver Cancer Among High-risk Patients
Authors
Tung T. Nguyen, MD
Ginny Gildengorin, PhD
Amy Truong
Stephen J. McPhee, MD
Publication date
01-04-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 4/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0128-1

Other articles of this Issue 4/2007

Journal of General Internal Medicine 4/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.